ETS vs VRTX · rev $726.8K vs P/E 30, rev $12.00B
Elite Express Holding Inc. Class A Common Stock (ETS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Elite Express Holding Inc. Class A Common Stock (ETS) is a trucking company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ETS revenue for 2026-05-31 was $726.8K. Net income was -$2.5M. Revenue was down 9.7% from 2026-02-28 to 2026-05-31. ETS currently screens at market cap $9.8M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ETS currently screens at market cap $9.8M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ETS and VRTX stock pages for the full models.
Not investment advice.